Log in
RegisterRoute of administration other than oral for concomitant medication [Bioanalytics]
Dear Qualityassurance,
I would say it depends on the bioavailability of these products when administered by these routes. For IV, no discussion (at least, if there is an active substance - don't bother about saline or glucose). But for a topical administration the answer is likely that there is no point.
❝ Can anyone suggest me 
if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?
I would say it depends on the bioavailability of these products when administered by these routes. For IV, no discussion (at least, if there is an active substance - don't bother about saline or glucose). But for a topical administration the answer is likely that there is no point.
—
Regards
Ohlbe
Regards
Ohlbe
Complete thread:
- Route of administration other than oral for concomitant medication qualityassurance 2020-02-04 11:28 [Bioanalytics]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Route of administration other than oral for concomitant medication jag009 2020-02-04 19:43
- Route of administration other than oral for concomitant medicationOhlbe 2020-02-05 10:13
- Route of administration other than oral for concomitant medication Dr_Dan 2020-02-11 16:20
Ing. Helmut Schütz